Class Action Over $28.1B Novartis, Alcon Deal Axed
A federal judge has dismissed a lawsuit from several pension funds and minority shareholders accusing Novartis AG of shortchanging them in its $28.1 billion merger with eye care company Alcon Inc.,...To view the full article, register now.
Already a subscriber? Click here to view full article